• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

National meeting??!!

Anonymous

Guest
I'm so glad we can work in the field next week and not have a meeting. I imagine the conference will be great...I wonder if we get to wait by the phone the next morning. That's how WHC did it.